Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 5Completed 4Withdrawn 3Recruiting 3Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 1

Interventions

Specimen Handling 11Magnetic Resonance Spectroscopy 9Cyclophosphamide 9Bevacizumab 7pembrolizumab 6Radiosurgery 6Cisplatin 6Oxaliplatin 5Nivolumab 5Irinotecan 5Fluorouracil 5Everolimus 5Capecitabine 5venetoclax 4Vincristine 4S 1 (combination) 4Prednisone 4Leucovorin 4Etoposide 4Drug Therapy 4Doxorubicin 4Biopsy 4Azacitidine 4fludarabine phosphate 3fludarabine 3Tacrolimus 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Rituximab 3Radiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × OTHER × fluoromisonidazole × Clear all
NCT04309552 2026-01-27

Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma

Weill Medical College of Cornell University

Phase 1 Suspended
8 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡